GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » ROE % Adjusted to Book Value

Jacobson Pharma (HKSE:02633) ROE % Adjusted to Book Value : 22.90% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Jacobson Pharma ROE % Adjusted to Book Value?

Jacobson Pharma's ROE % for the quarter that ended in Sep. 2024 was 11.68%. Jacobson Pharma's PB Ratio for the quarter that ended in Sep. 2024 was 0.51. Jacobson Pharma's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 22.90%.

Jacobson Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Jacobson Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobson Pharma ROE % Adjusted to Book Value Chart

Jacobson Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.80 12.82 20.22 20.00 21.33

Jacobson Pharma Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.59 18.19 21.54 19.82 22.90

Competitive Comparison of Jacobson Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jacobson Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Jacobson Pharma's ROE % Adjusted to Book Value falls into.


;
;

Jacobson Pharma ROE % Adjusted to Book Value Calculation

Jacobson Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.45% / 0.49
=21.33%

Jacobson Pharma's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.68% / 0.51
=22.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobson Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Jacobson Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobson Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:02552 HKSE:01061 HKSE:02348 HKSE:06896 HKSE:02161 HKSE:08049 HKSE:00950 HKSE:03737 HKSE:00239 HKSE:08329 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG
Website
http://www.jacobsonpharma.com
Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.
Executives
Queenshill Development Limited
Sum Kwong Yip, Derek 2305 Beneficiary of a trust
Lau Wing Hung
Kingshill Development Group Inc
Kingshill Development Limited
Ubs Trustees (b.v.i.) Limited
Longjin Investments Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si

Jacobson Pharma Headlines

No Headlines